BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28670357)

  • 41. A case report of jejunum transplantation in the treatment of severe cervical esophageal stricture in patients with dystrophic epidermolysis bullosa.
    Xu Z; Zhang Y; Hu Y; Xiu X; Yang B; Huang T; Huang Y
    Front Oncol; 2023; 13():1157563. PubMed ID: 38023129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrastructural findings in epidermolysis bullosa.
    Smith LT
    Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermolysis bullosa and cancer.
    Mallipeddi R
    Clin Exp Dermatol; 2002 Nov; 27(8):616-23. PubMed ID: 12472531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of life in people with epidermolysis bullosa: a systematic review.
    Togo CCG; Zidorio APC; Gonçalves VSS; Hubbard L; de Carvalho KMB; Dutra ES
    Qual Life Res; 2020 Jul; 29(7):1731-1745. PubMed ID: 32246433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genitourinary complications of inherited epidermolysis bullosa: experience of the national epidermylosis bullosa registry and review of the literature.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C
    J Urol; 2004 Nov; 172(5 Pt 1):2040-4. PubMed ID: 15540785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevalence of epidermolysis bullosa in Scotland.
    Horn HM; Priestley GC; Eady RA; Tidman MJ
    Br J Dermatol; 1997 Apr; 136(4):560-4. PubMed ID: 9155958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature.
    Yuen WY; Jonkman MF
    J Am Acad Dermatol; 2011 Oct; 65(4):780-789. PubMed ID: 21624701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Graftskin therapy in epidermolysis bullosa.
    Fivenson DP; Scherschun L; Choucair M; Kukuruga D; Young J; Shwayder T
    J Am Acad Dermatol; 2003 Jun; 48(6):886-92. PubMed ID: 12789180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.
    Condorelli AG; Dellambra E; Logli E; Zambruno G; Castiglia D
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pain care for patients with epidermolysis bullosa: best care practice guidelines.
    Goldschneider KR; Good J; Harrop E; Liossi C; Lynch-Jordan A; Martinez AE; Maxwell LG; Stanko-Lopp D;
    BMC Med; 2014 Oct; 12():178. PubMed ID: 25603875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hereditary epidermolysis bullosa.
    Wright JT; Fine JD
    Semin Dermatol; 1994 Jun; 13(2):102-7. PubMed ID: 8060821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C;
    Am J Kidney Dis; 2004 Oct; 44(4):651-60. PubMed ID: 15384016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular therapies for inherited epidermolysis bullosa.
    Has C
    G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practical and psychological problems for parents of children with epidermolysis bullosa.
    Lansdown R; Atherton D; Dale A; Sproston S; Lloyd J
    Child Care Health Dev; 1986; 12(4):251-6. PubMed ID: 3742737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunofluorescence antigen mapping for hereditary epidermolysis bullosa.
    Rao R; Mellerio J; Bhogal BS; Groves R
    Indian J Dermatol Venereol Leprol; 2012; 78(6):692-7. PubMed ID: 23075637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oleogel-S10 Phase 3 study "EASE" for epidermolysis bullosa: study design and rationale.
    Kern JS; Schwieger-Briel A; Löwe S; Sumeray M; Davis C; Martinez AE
    Trials; 2019 Jun; 20(1):350. PubMed ID: 31186047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidermolysis bullosa. Part 1: causes, presentation and complications.
    Pillay E
    Br J Nurs; 2008 Mar 13-26; 17(5):292-6. PubMed ID: 18414291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Birmingham Epidermolysis Bullosa Severity score: development and validation.
    Moss C; Wong A; Davies P
    Br J Dermatol; 2009 May; 160(5):1057-65. PubMed ID: 19434791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa.
    Fine JD; Horiguchi Y; Couchman JR
    Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abnormalities of plasma and erythrocyte essential fatty acid composition in epidermolysis bullosa: influence of treatment with diphenylhydantoin.
    Cunnane SC; Kent ET; McAdoo KR; Caldwell D; Lin AN; Carter DM
    J Invest Dermatol; 1987 Oct; 89(4):395-9. PubMed ID: 3668282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.